Centro de Investigación en Medicina Molecular e Enfermidades Crónicas (CIMUS)
Einzigartiges Zentrum
Instituto de Investigaciones Biomédicas de Barcelona
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Investigaciones Biomédicas de Barcelona (9)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
CPT1A in AgRP neurons is required for sex-dependent regulation of feeding and thirst
Biology of Sex Differences, Vol. 14, Núm. 1
2022
-
Soluble Epoxide Hydrolase Inhibitors: Design, Synthesis, in vitro Profiling and in vivo Evaluation in Murine Models of Pain
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 36
2021
-
Spread of a SARS-CoV-2 variant through Europe in the summer of 2020
Nature, Vol. 595, Núm. 7869, pp. 707-712
-
The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant
Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414
2017
2012
-
Identification in Silico and experimental validation of novel phosphodiesterase 7 inhibitors with efficacy in experimental autoimmune encephalomyelitis mice
ACS Chemical Neuroscience, Vol. 3, Núm. 10, pp. 793-803
2009
-
Evidence for distinct antagonist-revealed functional states of 5-hydroxytryptamine2A receptor homodimers
Molecular Pharmacology, Vol. 75, Núm. 6, pp. 1380-1391
2001
-
Multiple conformations of native and recombinant human 5-hydroxytryptamine2A receptors are labeled by agonists and discriminated by antagonists
Molecular Pharmacology, Vol. 60, Núm. 4, pp. 690-699